Market Cap 153.19M
Revenue (ttm) 0.00
Net Income (ttm) -24.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 564,600
Avg Vol 748,958
Day's Range N/A - N/A
Shares Out 111.82M
Stochastic %K 7%
Beta 0.82
Analysts Strong Sell
Price Target $6.74

Company Profile

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutan...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 289 910 0850
Fax: 905 481 2394
Address:
2265 Upper Middle Road East, Suite 602, Oakville, Canada
BlazingStocks
BlazingStocks Apr. 29 at 6:33 PM
$CRDL - The topics of the interview will be the ongoing pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis, the results from the recently published Phase II ARCHER trial of CardiolRx™ in acute myocarditis, and the Company's next generation drug, CRD-38, in development for heart failure. https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-highlight-maveric-phase-112700600.html
1 · Reply
Rbyild
Rbyild Apr. 29 at 5:42 PM
$CRDL Did anyone mention the pump…the profit taking and then reversion to its means? We’ve seen these unexplained pops many times in the last 3 - 4 years...and it’s proven very beneficial to simply trade them. At least it has for me. Yes, I still hold a fairly large core (currently 100,000 shares), but simply trade around it while waiting for readouts. Absent news or other insider purchases…it wouldn’t surprise me to see a low volume drift back toward the 50/200ma’s.
0 · Reply
NancyPelosi____insider
NancyPelosi____insider Apr. 29 at 2:48 PM
1 · Reply
NancyPelosi____insider
NancyPelosi____insider Apr. 29 at 2:36 PM
$CRDL like clockwork
0 · Reply
BlazingStocks
BlazingStocks Apr. 29 at 2:19 PM
$CRDL News April 14, 2026 Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-highlight-maveric-phase-112700600.html
0 · Reply
mmtiddy
mmtiddy Apr. 29 at 2:09 PM
$CRDL Start the descent back $1.00
1 · Reply
BigWig8560
BigWig8560 Apr. 29 at 1:41 PM
$CRDL so glad I blocked blazingstocks
0 · Reply
PDM21
PDM21 Apr. 29 at 1:34 PM
$CRDL Edesa biotech is an unrelated biotech to cardiol but they are right in the same area in Canada, they struggled for along time and had reverse splits etc, they were in the same price range as this for years with the same patterns, 2 months ago it was .80 premarket today they are in the $16 range. Some longs became millionaires in the past couple weeks from holding it. We will know if we are going to follow suit or get kicked in the bag here soon.
0 · Reply
NancyPelosi____insider
NancyPelosi____insider Apr. 29 at 12:58 PM
$CRDL going down again today with more accounts (blazingstocks) incessantly reposting news that everyone has already seen
1 · Reply
Covode13
Covode13 Apr. 29 at 12:05 PM
0 · Reply
Latest News on CRDL
Cardiol Therapeutics Announces Year-End 2025 Update on Operations

Wed, 01 Apr 2026 07:27:00 -0400 - 4 weeks ago

Cardiol Therapeutics Announces Year-End 2025 Update on Operations


Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Tue, 01 Apr 2025 07:27:00 -0400 - 1 year ago

Cardiol Therapeutics Announces Year-End 2024 Update on Operations


Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Wed, 13 Nov 2024 08:00:00 -0500 - 1 year ago

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index


Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today

2024-10-09T14:41:56.000Z - 1 year ago

Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today


Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Tue, 02 Apr 2024 06:00:00 -0400 - 2 years ago

Cardiol Therapeutics Announces Year-End 2023 Update on Operations


BlazingStocks
BlazingStocks Apr. 29 at 6:33 PM
$CRDL - The topics of the interview will be the ongoing pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis, the results from the recently published Phase II ARCHER trial of CardiolRx™ in acute myocarditis, and the Company's next generation drug, CRD-38, in development for heart failure. https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-highlight-maveric-phase-112700600.html
1 · Reply
Rbyild
Rbyild Apr. 29 at 5:42 PM
$CRDL Did anyone mention the pump…the profit taking and then reversion to its means? We’ve seen these unexplained pops many times in the last 3 - 4 years...and it’s proven very beneficial to simply trade them. At least it has for me. Yes, I still hold a fairly large core (currently 100,000 shares), but simply trade around it while waiting for readouts. Absent news or other insider purchases…it wouldn’t surprise me to see a low volume drift back toward the 50/200ma’s.
0 · Reply
NancyPelosi____insider
NancyPelosi____insider Apr. 29 at 2:48 PM
1 · Reply
NancyPelosi____insider
NancyPelosi____insider Apr. 29 at 2:36 PM
$CRDL like clockwork
0 · Reply
BlazingStocks
BlazingStocks Apr. 29 at 2:19 PM
$CRDL News April 14, 2026 Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-highlight-maveric-phase-112700600.html
0 · Reply
mmtiddy
mmtiddy Apr. 29 at 2:09 PM
$CRDL Start the descent back $1.00
1 · Reply
BigWig8560
BigWig8560 Apr. 29 at 1:41 PM
$CRDL so glad I blocked blazingstocks
0 · Reply
PDM21
PDM21 Apr. 29 at 1:34 PM
$CRDL Edesa biotech is an unrelated biotech to cardiol but they are right in the same area in Canada, they struggled for along time and had reverse splits etc, they were in the same price range as this for years with the same patterns, 2 months ago it was .80 premarket today they are in the $16 range. Some longs became millionaires in the past couple weeks from holding it. We will know if we are going to follow suit or get kicked in the bag here soon.
0 · Reply
NancyPelosi____insider
NancyPelosi____insider Apr. 29 at 12:58 PM
$CRDL going down again today with more accounts (blazingstocks) incessantly reposting news that everyone has already seen
1 · Reply
Covode13
Covode13 Apr. 29 at 12:05 PM
0 · Reply
BlazingStocks
BlazingStocks Apr. 28 at 7:04 PM
$CRDL - Growing interest in MAVERIC is expected to support the activation of up to seven additional U.S. clinical centers, with the total number anticipated to reach 25. https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-expands-u-maveric-112700641.html
0 · Reply
MikeTechnician
MikeTechnician Apr. 28 at 3:34 PM
$CRDL News Out : Cardiol Therapeutics Up In US Premarket As Expands Phase 3 Maveric Trial to Include 7 More Clinical Centers in the U.S. https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-us-premarket-expands-120756014.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Apr. 28 at 2:13 PM
🚨 $CRDL ON HIGH ALERT 🚨 Cardiol is expanding its U.S. MAVERIC Phase III trial network for CardiolRx™ in recurrent pericarditis. ✅ Enrollment now 75% ✅ Up to 7 new U.S. sites planned ✅ Total sites expected to reach 25 ✅ Recruitment target: Q2 2026 https://www.tiktok.com/@stocksonhighalert713/video/7633795810362248469 #MAVERIC #CardiolTherapeutics #ClinicalTrials #Biotech
0 · Reply
BlazingStocks
BlazingStocks Apr. 28 at 2:06 PM
$CRDL News April 28, 2026 Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-expands-u-maveric-112700641.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Apr. 28 at 1:00 PM
#FrontPageStocks News: $CRDL News! Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program https://www.stockonhighalert.com/post/crdl-cardiol-therapeutics-expands-u-s-maveric-phase-iii-trial-network-to-address-growing-interest #MAVERIC #CardiolTherapeutics #ClinicalTrials #Biotech @frontpagstocks #stocksonhighalert
1 · Reply
Zen000
Zen000 Apr. 28 at 12:37 PM
$CRDL https://ceo.ca/@newswire/cardiol-therapeutics-expands-us-maveric-phase-iii
0 · Reply
chronixxx
chronixxx Apr. 28 at 11:48 AM
$CRDL https://www.cardiolrx.com/cardiol-therapeutics-expands-u-s-maveric-phase-iii-trial-network-to-address-growing-interest-in-the-pivotal-program/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 12:10 AM
$CRDL RSI: 50.00, MACD: 0.0798 Vol: 0.09, MA20: 1.41, MA50: 1.18 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Covode13
Covode13 Apr. 27 at 9:25 PM
$CRDL hahahahah I had a heart attack for a hot second. I looked and saw 1.94 haha but it was the Canada price hahahah I was like wtf just happened.
2 · Reply
BlazingStocks
BlazingStocks Apr. 27 at 6:35 PM
$CRDL - Phase III MAVERIC in recurrent pericarditis is past 50% enrollment and is expected to reach full enrollment this quarter, with the FDA having sanctioned the study as a pivotal trial to support a new drug application. https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-ceo-phase-iii-101539470.html
0 · Reply
NancyPelosi____insider
NancyPelosi____insider Apr. 27 at 2:12 PM
$CRDL this guy doesn’t quit w/ the reposts
2 · Reply
BlazingStocks
BlazingStocks Apr. 27 at 2:07 PM
$CRDL News April 15, 2026 Cardiol Therapeutics CEO: Phase III MAVERIC Nears Full Enrollment as CardiolRx Shows Myocarditis Promise https://finance.yahoo.com/sectors/healthcare/articles/cardiol-therapeutics-ceo-phase-iii-101539470.html
0 · Reply